SEC Suspends China Medical Technologies (CMEDY)
Tweet Send to a Friend
The Securities and Exchange Commission announced the temporary suspension, pursuant to Section 12(k) of the Securities Exchange Act of 1934, of trading in the securities of China Medical Technologies, Inc. (OTC: CMEDY), of the People’s Republic of China, at 9:30 a.m. on June 29, 2012, and terminating at 11:59 p.m. on July 13, 2012.
The Commission temporarily suspended trading in the securities of China Medical because of questions that have been raised about the accuracy and adequacy of publicly disseminated information concerning, among other things, the status of the company’s officers and directors, the accuracy of the company’s financial statements and filings with the Commission, and the current financial condition of the company.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The Commission temporarily suspended trading in the securities of China Medical because of questions that have been raised about the accuracy and adequacy of publicly disseminated information concerning, among other things, the status of the company’s officers and directors, the accuracy of the company’s financial statements and filings with the Commission, and the current financial condition of the company.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Kansas City Southern (KSU) to Replace Dean Foods (DF) in S&P 500; WhiteWave Foods (WWAV) to S&P MidCap 400
- Tableau Software (DATA) IPO now indicated $42-$44
- Apple (AAPL) Streaming Music Service Could be Delayed - The Verge
Create E-mail Alert Related Categories
Trader Talk, Trading Halts
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
